Jenny Lorena Rico Duque

Title: Jenny Lorena Rico Duque: Innovator in Pharmaceutical Chemistry

Introduction

Jenny Lorena Rico Duque is a prominent inventor based in Boston, MA. She has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents, her work is recognized for its potential impact on treating various diseases.

Latest Patents

Jenny's latest patents include innovative compounds that serve as adenosine receptor antagonists. The first patent, titled "Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine receptor antagonists, pharmaceutical compositions and their use," outlines compounds that can be used in the treatment of diseases mediated by the adenosine A2a and A2b receptors. The second patent, "Spirotricycle RIPK1 inhibitors and methods of uses thereof," describes compounds that act as RIPK1 inhibitors, which can be beneficial in addressing RIPK1-related diseases.

Career Highlights

Jenny is currently employed at Merck Sharp & Dohme Corp., where she continues to advance her research and development efforts. Her work is characterized by a commitment to innovation and excellence in pharmaceutical sciences.

Collaborations

Throughout her career, Jenny has collaborated with notable colleagues, including Zachary G Brill and Abdelghani Achab. These partnerships have contributed to her success and the advancement of her research projects.

Conclusion

Jenny Lorena Rico Duque is a trailblazer in pharmaceutical chemistry, with a focus on developing innovative therapeutic compounds. Her contributions through her patents and collaborations highlight her dedication to improving healthcare outcomes.